1. Academic Validation
  2. VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans

VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans

  • Hum Mutat. 2012 Feb;33(2):364-8. doi: 10.1002/humu.21658.
Anne M Slavotinek 1 Ryan Chao Tomas Vacik Mani Yahyavi Hana Abouzeid Tanya Bardakjian Adele Schneider Gary Shaw Elliott H Sherr Greg Lemke Mohammed Youssef Daniel F Schorderet
Affiliations

Affiliation

  • 1 Department of Pediatrics, Division of Genetics, University of California, San Francisco, California 94143-0748, USA. [email protected]
Abstract

Vax1 and Vax2 have been implicated in eye development and the closure of the choroid fissure in mice and zebrafish. We sequenced the coding exons of VAX1 and VAX2 in 70 patients with anophthalmia/microphthalmia (A/M). In VAX1, we observed homozygosity for two successive nucleotide substitutions c.453G>A and c.454C>A, predicting p.Arg152Ser, in a proband of Egyptian origin with microphthalmia, small optic nerves, cleft lip/palate, and corpus callosum agenesis. This mutation affects an invariant residue in the homeodomain of VAX1 and was absent from 96 Egyptian controls. It is likely that the mutation results in a loss of function, as the mutation results in a phenotype similar to the Vax1 homozygous null mouse. We did not identify any mutations in VAX2. This is the first description of a phenotype associated with a VAX1 mutation in humans and establishes VAX1 as a new causative gene for A/M.

Figures